About The Study: This study of 18,000 residents of long-term care facilities in Israel found that those who had received a third dose (first booster dose) of the Pfizer-BioNTech vaccine had a significantly lower risk for overall SARS-CoV-2 infection, COVID-19 hospitalizations, severe disease and related deaths during the Delta variant surge compared with those who received two doses five months or longer prior to the potential exposure.
Authors: Khitam Muhsen, Ph.D., of Tel Aviv University, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.19940?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=070122
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
JAMA Network Open